These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 7751878)
61. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity. Schwartz Z; Bowe RB; Coleman M; Magro CM Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067 [TBL] [Abstract][Full Text] [Related]
62. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893 [TBL] [Abstract][Full Text] [Related]
63. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders. Martires KJ; Ra S; Abdulla F; Cassarino DS Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239 [TBL] [Abstract][Full Text] [Related]
64. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin. Werner B; Massone C; Kerl H; Cerroni L J Cutan Pathol; 2008 Dec; 35(12):1100-7. PubMed ID: 18616762 [TBL] [Abstract][Full Text] [Related]
65. A Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder Arising in a Patient With Multiple Myeloma and Cutaneous Amyloidosis. Romano RC; Cohen DN; Howard MT; Wieland CN Am J Dermatopathol; 2016 May; 38(5):388-92. PubMed ID: 26981738 [TBL] [Abstract][Full Text] [Related]
68. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood. Tomaszewski MM; Moad JC; Lupton GP J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635 [TBL] [Abstract][Full Text] [Related]
69. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Herbst H; Sander C; Tronnier M; Kutzner H; Hügel H; Kaudewitz P Br J Dermatol; 1997 Nov; 137(5):680-6. PubMed ID: 9415224 [TBL] [Abstract][Full Text] [Related]
70. Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG). Blanchard M; Morren MA; Busschots AM; Hauben E; Alberti-Violetti S; Berti E; Avallone G; Tavoletti G; Panzone M; Quaglino P; Colonna C; Melchers RC; Vermeer MH; Gniadecki R; Mitteldorf C; Gosmann J; Stadler R; Jonak C; Oren-Shabtai M; Hodak E; Friedland R; Gordon E; Geskin LJ; Scarisbrick JJ; Mayo Martínez F; Noguera Morel L; Pehr K; Amarov B; Faouzi M; Nicolay JP; Kempf W; Blanchard G; Guenova E Br J Dermatol; 2024 Jul; 191(2):233-242. PubMed ID: 38595050 [TBL] [Abstract][Full Text] [Related]
71. Anaplastic large cell lymphoma: an unusual presentation in a 7-year-old girl. Ju E; Adigun C; Dunphy C; Gold S; Morrell DS Pediatr Dermatol; 2012; 29(4):498-503. PubMed ID: 21967522 [TBL] [Abstract][Full Text] [Related]
72. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Sciallis AP; Law ME; Inwards DJ; McClure RF; Macon WR; Kurtin PJ; Dogan A; Feldman AL Mod Pathol; 2012 Jul; 25(7):983-92. PubMed ID: 22388754 [TBL] [Abstract][Full Text] [Related]
73. [Prognosis of primary cutaneous lymphomas]. Grange F; Bagot M Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927 [TBL] [Abstract][Full Text] [Related]
74. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. Vonderheid EC; Sajjadian A; Kadin ME J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262 [TBL] [Abstract][Full Text] [Related]
75. Lymphomatoid papulosis in children: a series of 25 cases. Miquel J; Fraitag S; Hamel-Teillac D; Molina T; Brousse N; de Prost Y; Bodemer C Br J Dermatol; 2014 Nov; 171(5):1138-46. PubMed ID: 24749749 [TBL] [Abstract][Full Text] [Related]
76. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review. Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988 [TBL] [Abstract][Full Text] [Related]
77. Apoptosis in CD30-positive lymphoproliferative disorders of the skin. Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132 [TBL] [Abstract][Full Text] [Related]
78. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil. Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798 [TBL] [Abstract][Full Text] [Related]
79. Intraoral CD30+ T-Cell Lymphoproliferative Disorder with Lymphomatoid Papulosis Type C Features Mimics Lymphoma Histopathologically and Immunohistochemically. Barbeiro CO; Silveira HA; Barbeiro RH; Martins KH; Bufalino A; Chahud F; León JE Head Neck Pathol; 2024 Jun; 18(1):60. PubMed ID: 38941041 [TBL] [Abstract][Full Text] [Related]